tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe FlyMidday Fly By: Warner Bros. urges investors to reject Paramount bid
2M ago
Immunome falls -7.2%
Premium
The Fly
Immunome falls -7.2%
2M ago
Immunome 18.625M share Spot Secondary priced at $21.50
Premium
The Fly
Immunome 18.625M share Spot Secondary priced at $21.50
2M ago
Immunome offers to sell $400M in common stock
PremiumThe FlyImmunome offers to sell $400M in common stock
2M ago
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
Premium
Ratings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
2M ago
Immunome price target raised to $40 from $38 at Leerink
Premium
The Fly
Immunome price target raised to $40 from $38 at Leerink
2M ago
Immunome reports RINGSIDE trial met primary, secondary endpoints
PremiumThe FlyImmunome reports RINGSIDE trial met primary, secondary endpoints
2M ago
Immunome Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Immunome Announces Positive Phase 3 Trial Results
2M ago
Immunome initiated with a Buy at Truist
Premium
The Fly
Immunome initiated with a Buy at Truist
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100